Chancellor Reeves Plans Focused Action on Living Costs in Upcoming Financial Plan
Treasury head Rachel Reeves has announced she is preparing "targeted steps to deal with household expense issues" in next month's Budget.
Speaking to media outlets, she emphasized that curbing price rises is a shared duty of both the government and the Bank of England.
The United Kingdom's price growth is expected to be the highest among the Group of Seven developed nations this calendar year and the following year.
Possible Energy Bill Measures
Sources suggest the government could intervene to bring down energy bills, for example by cutting the current 5% rate of VAT applied on energy.
An additional possibility is to reduce some of the regulatory levies presently included in household expenses.
Budgetary Constraints and Analyst Expectations
The government will receive the latest draft from the official forecaster, the OBR, on Monday, which will show how much room there is for these actions.
The expectation from the majority of experts is that Reeves will have to declare tax rises or expenditure reductions in order to adhere to her declared fiscal targets.
Earlier on Thursday, calculations showed there was a ÂŁ22 billion deficit for the chancellor to resolve, which is at the more modest range of forecasts.
"It is a joint responsibility between the Bank of England and the administration to continue tackling some of the sources of inflation," the Chancellor stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.
Revenue Pledges and Global Issues
While a great deal of the attention has been on probable tax rises, the chancellor said the most recent information from the fiscal watchdog had not changed her commitment to election pledges not to increase rates on income tax, VAT or social security contributions.
She attributed an "unpredictable world" with rising geopolitical and commercial tensions for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."
International Economic Disputes
Referring to apprehensions about the UK's economic relations with China she said: "The UK's national security always take priority."
Recent announcement by China to increase trade restrictions on rare earths and other materials that are key for high-technology production led American leader the US President to threaten an extra 100% import tax on imports from the Asian country, increasing the possibility of an full-scale commercial conflict between the two largest economies.
The American finance chief called China's action "economic coercion" and "a international production power grab."
Questioned on accepting the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's actions and called on the Beijing authorities "not to put up barriers and restrict access."
She said the action was "harmful for the global economy and generates further obstacles."
"In my view there are areas where we must challenge China, but there are also valuable prospects to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance correct."
The Treasury chief also stated she was collaborating with G7 counterparts "on our own essential resources strategy, so that we are reduced dependence."
NHS Drug Costs and Investment
Reeves also admitted that the price the NHS pays for medicines could increase as a result of current talks with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.
Some of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or canceling projects in the UK, with several attributing the insufficient payments they are obtaining.
Recently, the Science Minister said the cost the NHS pays for drugs would must go up to halt firms and drug research funding departing from the UK.
Reeves told media: "We have seen because of the payment system, that clinical trials, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other continental states."
"Our aim is to make sure that individuals getting treatment from the NHS are can obtain the finest critical drugs in the world. And so we are examining these issues, and... aiming to obtain increased capital into Britain."